Sign in
4

Changes in Ownership

REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-23-000009

Director sold 3,070 shares at $798.42 ($2,451,149)

  • Director acquired 3,070 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BROWN MICHAEL S · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-04-21 Exercise or conversion : show line 1 in the form 10b5-1 +3,070 $520.01 $1,596,431 4,317 D
2023-04-21 Sale : show line 2 in the form 10b5-1 −3,070 $798.42 $2,451,149 1,247 D
Open-market sales · 3,070 sh · avg $798.42 · $2,451,149

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-04-21 Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −3,070 0 D
Loading xslF345X04/edgardoc.xml…